Budget-friendly Nsc-66811 P53/mdm2 Inhibitor (tbi1334) New Style [Epnvqaf6]

NSC-66811: Advanced p53/mdm2 Inhibitor

Introducing NSC-66811, a cutting-edge p53/mdm2 inhibitor designed to revolutionize cancer research and treatment. This novel compound, known as TBI1334, boasts a unique mechanism of action that targets the MDM2-p53 interaction. With its high purity of over 98%, NSC-66811 is a reliable tool for scientists and researchers in the field of oncology.

• High Purity: Over 98% purity ensures consistent and reliable results.
• Cell Permeable: Easily crosses cell membranes for effective inhibition.

Product Specifications and Technical Details

NSC-66811, formally known as 2-Methyl-7-[Phenyl(phenylamino)methyl]-8-quinolinol, has a molecular formula of C₂₃H₂₀N₂O and a formula weight of 340.43. It is available as a powder and is highly soluble in DMSO, up to 25 mg/ml. With a storage stability of ≥ 2 years at room temperature, NSC-66811 is a cost-effective and long-lasting research tool.

• Molecular Formula: C₂₃H₂₀N₂O
• Formula Weight: 340.43
• Storage: RT, ≥ 2 years

Applications and Benefits

NSC-66811 is a powerful inhibitor of the MDM2-p53 interaction, mimicking three p53 residues involved in binding to MDM2. Its low Ki value of 120 nM demonstrates its high affinity for MDM2. By activating p53 in cancer cells, this compound has the potential to disrupt the growth and progression of tumors. Its cell permeability makes it ideal for use in various experimental settings. Whether you're a researcher in oncology or a pharmaceutical scientist, NSC-66811 offers a versatile and effective solution for your needs.

• Activates p53: Disrupts cancer cell growth and progression.
• Cell Permeable: Enables effective inhibition in various experimental settings.